344 related articles for article (PubMed ID: 22402315)
1. Prostate cancer stem cell biology.
Yu C; Yao Z; Jiang Y; Keller ET
Minerva Urol Nefrol; 2012 Mar; 64(1):19-33. PubMed ID: 22402315
[TBL] [Abstract][Full Text] [Related]
2. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer stem cells.
Yao T; Lu R; Zhang Y; Zhang Y; Zhao C; Lin R; Lin Z
Cell Prolif; 2015 Dec; 48(6):611-25. PubMed ID: 26597379
[TBL] [Abstract][Full Text] [Related]
4. Revisiting the concept of cancer stem cells in prostate cancer.
Wang ZA; Shen MM
Oncogene; 2011 Mar; 30(11):1261-71. PubMed ID: 21119602
[TBL] [Abstract][Full Text] [Related]
5. Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy.
Leão R; Domingos C; Figueiredo A; Hamilton R; Tabori U; Castelo-Branco P
Urol Int; 2017; 99(2):125-136. PubMed ID: 28142149
[TBL] [Abstract][Full Text] [Related]
6. Stem cells: The root of prostate cancer?
Kasper S
J Cell Physiol; 2008 Aug; 216(2):332-6. PubMed ID: 18459113
[TBL] [Abstract][Full Text] [Related]
7. Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology.
Kyriazi AA; Papiris E; Kitsos Kalyvianakis K; Sakellaris G; Baritaki S
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932969
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer stem cells: do they have a basal or luminal phenotype?
Maitland NJ; Frame FM; Polson ES; Lewis JL; Collins AT
Horm Cancer; 2011 Feb; 2(1):47-61. PubMed ID: 21761340
[TBL] [Abstract][Full Text] [Related]
9. Cancer Stem Cells and Prostate Cancer: A Narrative Review.
Al Salhi Y; Sequi MB; Valenzi FM; Fuschi A; Martoccia A; Suraci PP; Carbone A; Tema G; Lombardo R; Cicione A; Pastore AL; De Nunzio C
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175453
[TBL] [Abstract][Full Text] [Related]
10. Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens.
Kasper S
Urol Oncol; 2009; 27(3):301-3. PubMed ID: 19414117
[TBL] [Abstract][Full Text] [Related]
11. Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity.
Vummidi Giridhar P; Williams K; VonHandorf AP; Deford PL; Kasper S
Cancer Res; 2019 Mar; 79(6):1124-1137. PubMed ID: 30626627
[TBL] [Abstract][Full Text] [Related]
12. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
Liu R; Liu C; Zhang D; Liu B; Chen X; Rycaj K; Jeter C; Calhoun-Davis T; Li Y; Yang T; Wang J; Tang DG
Oncotarget; 2016 Aug; 7(35):56628-56642. PubMed ID: 27447749
[TBL] [Abstract][Full Text] [Related]
13. New insights into prostate cancer stem cells.
Chen X; Rycaj K; Liu X; Tang DG
Cell Cycle; 2013 Feb; 12(4):579-86. PubMed ID: 23370446
[TBL] [Abstract][Full Text] [Related]
14. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
15. TAp63 and ΔNp63 (p40) in prostate adenocarcinomas: ΔNp63 associates with a basal-like cancer stem cell population but not with metastasis.
Galoczova M; Nenutil R; Pokorna Z; Vojtesek B; Coates PJ
Virchows Arch; 2021 Apr; 478(4):627-636. PubMed ID: 33037932
[TBL] [Abstract][Full Text] [Related]
16. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
[TBL] [Abstract][Full Text] [Related]
17. Non-coding RNAs in Prostate Cancer: From Discovery to Clinical Applications.
Ceder Y
Adv Exp Med Biol; 2016; 886():155-170. PubMed ID: 26659491
[TBL] [Abstract][Full Text] [Related]
18. Enrichment of the Cancer Stem Phenotype in Sphere Cultures of Prostate Cancer Cell Lines Occurs through Activation of Developmental Pathways Mediated by the Transcriptional Regulator ΔNp63α.
Portillo-Lara R; Alvarez MM
PLoS One; 2015; 10(6):e0130118. PubMed ID: 26110651
[TBL] [Abstract][Full Text] [Related]
19. Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid.
Bizzarro V; Belvedere R; Milone MR; Pucci B; Lombardi R; Bruzzese F; Popolo A; Parente L; Budillon A; Petrella A
Oncotarget; 2015 Sep; 6(28):25076-92. PubMed ID: 26312765
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.
Caputo S; Grioni M; Brambillasca CS; Monno A; Brevi A; Freschi M; Piras IS; Elia AR; Pieri V; Baccega T; Lombardo A; Galli R; Briganti A; Doglioni C; Jachetti E; Bellone M
Front Immunol; 2020; 11():1820. PubMed ID: 33013832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
